YM598, an Orally Active ETA Receptor Antagonist, Ameliorates the Progression of Cardiopulmonary Changes and Both-side Heart Failure in Rats with Cor Pulmonale and Myocardial Infarction
暂无分享,去创建一个
A. Fujimori | K. Sudoh | I. Yamaguchi | T. Miyauchi | K. Goto | M. Iemitsu | S. Sakai | H. Shikama | H. Yuyama | M. Sanagi